8-K: Warby Parker Reports 12% Revenue Growth for 2023, Expands Vision Care Access

Warby Parker announced a 12% increase in net revenue for 2023, reaching $669.8 million, alongside an expansion of their in-network vision benefits to over 34 million lives.

Summary

• Warby Parker's net revenue for 2023 increased by 12% to $669.8 million, up from $598.1 million in 2022.
• The average revenue per customer rose by 9.3% year-over-year to $287.
• The company's full-year GAAP net loss was $63.2 million, while the fourth-quarter net loss was $19.0 million.
• Adjusted EBITDA for the full year was $52.4 million, with a margin of 7.8%, and for the fourth quarter, it was $9.4 million with a margin of 5.8%.
• Warby Parker opened 40 new stores in 2023, bringing the total to 237 stores.
• Net cash from operating activities was $61.0 million in 2023, compared to $10.4 million in 2022.
• The company generated $7.3 million in free cash flow for the full year.
• Over 15 million pairs of glasses have been distributed through their 'Buy a Pair, Give a Pair' program.
• The company has expanded its relationship with Versant Health, increasing in-network access to over 34 million lives.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong revenue growth and strategic initiatives, but the net loss and margin pressures temper the overall sentiment. The expansion of in-network access and the new credit facility are positive indicators.

Positives

• The company experienced double-digit revenue growth each quarter in 2023.
• Margins improved throughout the year.
• The company is expanding its retail presence and omnichannel experiences.
• Warby Parker has a strong commitment to social impact through its 'Buy a Pair, Give a Pair' program.
• The company has a new $120 million revolving credit facility which remains undrawn.

Negatives

• The company reported a full-year GAAP net loss of $63.2 million.
• Gross margin decreased from 57.0% to 54.5% year-over-year, primarily due to contact lens sales and increased store costs.
• Selling, general, and administrative expenses increased in the fourth quarter due to higher compensation, marketing, and technology costs.

Risks

• The company faces risks related to managing future growth effectively.
• Changes in component and shipping costs and supply chain issues could impact results.
• Reliance on information technology systems and potential cybersecurity incidents pose a risk.
• The company is subject to economic downturns and changes in consumer spending.
• Competition in the eyewear market could affect the company's performance.
• The company must manage inventory balances and shrinkage effectively.
• The company needs to recruit and retain optometrists, opticians, and other vision care professionals.
• The company is subject to extensive laws and regulations.
• The company relies on third parties for products, operations and infrastructure.

Future Outlook

Warby Parker projects net revenue of $748 to $758 million for 2024, representing approximately 12% to 13% growth, and adjusted EBITDA of $67 million at the midpoint of the revenue range, with an adjusted EBITDA margin of 8.9%. The company also plans to open 40 new stores in 2024.

Management Comments

• Co-Founder and Co-CEO Neil Blumenthal stated that 2023 was a year in which the company executed on its commitment to growing sustainably, delivering double-digit revenue growth each quarter while improving margins and creating exceptional customer experiences.
• Co-Founder and Co-CEO Dave Gilboa mentioned the company's excitement to meet millions of customers where and how they want to shop as they expand their retail presence and nearly double the number of insured lives who can use their in-network vision benefits.
• Chief Financial Officer Steve Miller stated that the leadership team remains focused on delivering strong topline and bottomline results that speak to Warby Parker's brand strength, disciplined cost management, and strategic vision as a holistic vision care company.

Industry Context

Warby Parker's results reflect a continued trend of growth in the direct-to-consumer eyewear market, with a focus on omnichannel experiences and expanding access to vision care. The expansion of in-network benefits aligns with a broader industry trend of integrating vision care with health insurance plans.

Comparison to Industry Standards

• While Warby Parker's 12% revenue growth is solid, it is important to compare it to other direct-to-consumer eyewear companies such as Zenni Optical and online retailers like Amazon who also sell eyewear.
• The adjusted EBITDA margin of 7.8% for the full year is a key metric to compare against peers in the retail and eyewear sectors, such as Luxottica and EssilorLuxottica, who have higher margins due to their scale and vertical integration.
• The company's store expansion strategy is similar to other retailers, but the focus on integrated eye exams in stores is a differentiator.
• The expansion of in-network access to over 34 million lives is a significant move, and its impact should be compared to other vision care providers like VSP and EyeMed.

Stakeholder Impact

• Shareholders will be impacted by the revenue growth and profitability metrics.
• Employees will be affected by the company's expansion and hiring plans.
• Customers will benefit from increased access to vision care and retail locations.
• Suppliers will be impacted by the company's growth and demand for products.
• Creditors will be impacted by the company's financial performance and credit facility.

Next Steps

• Warby Parker will continue to expand its retail presence with 40 new store openings in 2024.
• The company will focus on deploying disciplined marketing spend to support growth across its omnichannel experiences.
• The company will work to integrate the additional 15 million lives into their in-network vision benefits later this year.

Key Dates

Keywords

Warby Parker, eyewear, vision care, retail, direct-to-consumer, financial results, revenue growth, EBITDA, net loss, store expansion, omnichannel, customer experience, contact lenses, gross margin, operating activities, free cash flow, in-network, Versant Health